BE808008A - Nouveaux derives de l'imidazo (2,1-b) thiazole - Google Patents

Nouveaux derives de l'imidazo (2,1-b) thiazole

Info

Publication number
BE808008A
BE808008A BE138342A BE138342A BE808008A BE 808008 A BE808008 A BE 808008A BE 138342 A BE138342 A BE 138342A BE 138342 A BE138342 A BE 138342A BE 808008 A BE808008 A BE 808008A
Authority
BE
Belgium
Prior art keywords
imidazo
thiazole
new derivatives
derivatives
new
Prior art date
Application number
BE138342A
Other languages
English (en)
French (fr)
Inventor
Des Usines Chimiques Rhone-Poulenc. Soc.
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7242580A external-priority patent/FR2207708A1/fr
Priority claimed from FR7335158A external-priority patent/FR2245348A1/fr
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of BE808008A publication Critical patent/BE808008A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE138342A 1972-11-30 1973-11-29 Nouveaux derives de l'imidazo (2,1-b) thiazole BE808008A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7242580A FR2207708A1 (en) 1972-11-30 1972-11-30 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity
FR7335158A FR2245348A1 (en) 1973-10-02 1973-10-02 2-Aryl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazoles - with antidepressant, psychoenergising and anorectic activity

Publications (1)

Publication Number Publication Date
BE808008A true BE808008A (fr) 1974-05-29

Family

ID=26217429

Family Applications (1)

Application Number Title Priority Date Filing Date
BE138342A BE808008A (fr) 1972-11-30 1973-11-29 Nouveaux derives de l'imidazo (2,1-b) thiazole

Country Status (20)

Country Link
US (1) US4005212A (ja)
JP (1) JPS5314077B2 (ja)
AR (1) AR203186A1 (ja)
AT (1) AT329554B (ja)
BE (1) BE808008A (ja)
CA (1) CA1002955A (ja)
CH (1) CH579577A5 (ja)
DD (1) DD107697A5 (ja)
DE (1) DE2359864A1 (ja)
DK (1) DK136823B (ja)
ES (1) ES421011A1 (ja)
GB (1) GB1404708A (ja)
HU (1) HU167368B (ja)
IE (1) IE38552B1 (ja)
IL (1) IL43723A (ja)
LU (1) LU68887A1 (ja)
NL (1) NL7316016A (ja)
OA (1) OA04567A (ja)
SE (1) SE399894B (ja)
SU (1) SU518133A3 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179460A (en) * 1977-07-06 1979-12-18 Dso "Pharmachim" Derivatives of R,S-[X2-(2-hydroxyethylamino)-1-phenyl]-ethylamine, and process
US4370482A (en) 1978-02-15 1983-01-25 American Cyanamid Co. Synthesis of tetramisole, levamisole and their derivatives
US4620009A (en) * 1980-03-17 1986-10-28 Cyanamid Agricultural De Puerto Rico, Inc. Synthesis of intermediates for tetramisole, levamisole and their derivatives
ZA827736B (en) * 1981-11-25 1983-08-31 Pfizer Bicyclic imidazole and imidazolines as ectoparasiticides and anthelmintics
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby

Also Published As

Publication number Publication date
GB1404708A (en) 1975-09-03
JPS4993390A (ja) 1974-09-05
DD107697A5 (ja) 1974-08-12
IE38552B1 (en) 1978-04-12
IL43723A (en) 1976-07-30
DE2359864A1 (de) 1974-06-06
ES421011A1 (es) 1976-06-16
CH579577A5 (ja) 1976-09-15
US4005212A (en) 1977-01-25
AT329554B (de) 1976-05-25
HU167368B (ja) 1975-09-27
CA1002955A (fr) 1977-01-04
JPS5314077B2 (ja) 1978-05-15
IE38552L (en) 1974-05-30
SE399894B (sv) 1978-03-06
LU68887A1 (ja) 1974-07-05
DK136823C (ja) 1978-05-08
AR203186A1 (es) 1975-08-22
OA04567A (fr) 1980-05-31
SU518133A3 (ru) 1976-06-15
AU6300973A (en) 1975-05-29
DK136823B (da) 1977-11-28
IL43723A0 (en) 1974-03-14
NL7316016A (ja) 1974-06-04
ATA1005173A (de) 1975-08-15

Similar Documents

Publication Publication Date Title
BE779128A (fr) Nouveaux derives de benzazine
BE821406A (fr) Derives de 1
PT66278B (fr) Procede de preparation de nouveaux derives de 2,3-dihydro imidazo /2,1-b/ thiazole
BE809169A (fr) Derives de la famille des delta 2-prostaglandines
BE820789A (fr) Nouveaux derives de l'isoquinoleine
BE813021A (fr) Nouveaux derives de pyrido(1
AR214383A1 (es) Derivados de dialquilfosfanatos
BE821571A (fr) Nouveaux derives de la phenylpropenylamine
BE808008A (fr) Nouveaux derives de l'imidazo (2,1-b) thiazole
BE801965A (fr) Nouveaux derives de beta-phenoxyethanols
BE806363A (fr) Composes nouveaux de 3,4-dihydro-hh-pyrane-2,4-diones
BE822780A (fr) Derives de cepheme
AR201288A1 (es) Derivados de alfa-cianmetansulfonamidobenceno
BE824037A (fr) Nouveaux derives de l'imidazo (2,1a) isoquinoleine
FR2292476A1 (fr) Derives de la quinoleine
BE822239A (fr) Nouveaux derives de la quinoleine
BE795041A (fr) Nouveaux derives de l'amino-propane
BE822029A (fr) Nouveaux derives de la thiazolyluree
BE799615A (fr) Nouveaux derives de la 6alpha-methylprednisolone
BE802797A (fr) Nouveaux derives de beta-aminocetones
BE808147A (fr) Nouveaux derives de 2'-fluorobiphenyles
BE812134R (fr) Nouveaux derives de 1
FI55664C (fi) Foerfarande foer framstaellning av blodtryckssaenkande 5-oxo-2,3-dihydro-imidazo-(1,2-a)-s-triaziner
DD106186A5 (de) Herstellung von cephalosporinderivaten
BE802662A (fr) Nouveaux derives de la quinazolinone